Management of postoperative vomiting in pediatric patients

Current Opinion in Anaesthesiology

Volumn 16, Issue 6, 2003, Pages 575-583

  Watcha, Mehernoor F ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Ambulatory anesthesia; Anesthesic complications; Antiserotonin drugs; Droperidol; Pediatrics; Postoperative nausea and vomiting

Indexed keywords

ANESTHETIC AGENT; ANTIEMETIC AGENT; ATROPINE; BENZAMIDE DERIVATIVE; BUTYROPHENONE DERIVATIVE; CYCLOPROPANE; DESFLURANE; DICLOFENAC; DIMENHYDRINATE; DROPERIDOL; EDROPHONIUM; ETHER; FENTANYL CITRATE; GLYCOPYRRONIUM BROMIDE; HALOTHANE; IBUPROFEN; ISOFLURANE; KETAMINE; KETOROLAC; NEOSTIGMINE; NITROUS OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; ONDANSETRON; OPIATE; PARACETAMOL; PROPOFOL; SCOPOLAMINE; SEVOFLURANE; THIOPENTAL; UNINDEXED DRUG;

ANESTHESIST; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG INFUSION; DRUG UTILIZATION; HEALTH CARE ORGANIZATION; HIGH RISK PATIENT; HUMAN; INCIDENCE; NURSING; OPERATION DURATION; PAIN; PATIENT CARE; PATIENT POSITIONING; PATIENT SATISFACTION; POSTOPERATIVE NAUSEA; POSTOPERATIVE PAIN; POSTOPERATIVE VOMITING; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEDATION; SIDE EFFECT; SURGICAL PATIENT; SURGICAL TECHNIQUE; TREATMENT INDICATION; VISUAL DISORDER; XEROSTOMIA;

EID: 2942582346     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200312000-00002     Document Type: Review

References (58)

1. Rose JB, Watcha MF. Postoperative nausea and vomiting in paediatric patients. Br J Anaesth 1999; 83:104-117.
2. Cameron D, Gan TJ. Management of postoperative nausea and vomiting in ambulatory surgery. Anesth Clin North America 2003; 21:347-365. Recent review of the problem of PONV in adults and children.
3. Gan TJ, Meyer T, Apfel CC, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003; 97:62-71. Most important paper describing the view of a number of experts who make recommendations on how to evaluate the risk of PONV, what steps to take to reduce the risk and how to manage patients.
4. Apfel CC, Kranke P, Greim CA, Roewer N. What can be expected from risk scores for predicting postoperative nausea and vomiting? Br J Anaesth 2001; 86:822-827.
5. Kranke P, Apfel CC, Papenfuss T, et al. An increased body mass index is no risk factor for postoperative nausea and vomiting: a systematic review and results of original data. Acta Anaesth Scand 2003; 45:160-166. Contrary to traditional teaching, these authors have carefully tested the hypothesis that obesity is associated with POV and could not prove the association after allowing for confounding factors. They found the duration of surgery was important. However, what is unclear is if obesity increases the technical difficulty of the surgery and so prolongs the procedure.
6. Wang SM, Kain ZN. Preoperative anxiety and postoperative nausea and vomiting in children: is there an association? Anesth Analg 2000; 90:571-575.
7. Apfel CC, Greim CA, Haubitz I, Goepfert C, et al. A risk score to predict the probability of postoperative vomiting in adults [comment]. Acta Anaesth Scand 1998; 42:495-501.
8. Rowley MP, Brown TCK. Postoperative vomiting in children. Anaesth Intensive Care 1982; 10:309-313.
9. Tramer MR. A rational approach to the control of postoperative nausea and vomiting: evidence from systematic reviews. Part II: Recommendations for prevention and treatment, and research agenda. Acta Anaesth Scand 2001; 45:14-19.
10. Tramer MR. A rational approach to the control of postoperative nausea and vomiting: evidence from systematic reviews. Part I: Efficacy and harm of antiemetic interventions, and methodological issues. Acta Anaesth Scand 2001; 45:4-13.
11. Divatia JV, Vaidya JS, Badwe RA, Hawaldar RW. Omission of nitrous oxide during anesthesia reduces the incidence of postoperative nausea and vomiting: a meta-analysis. Anesthesiology 1996; 85:1055-1062.
12. Tramer M, Moore A, McQuay H. Omitting nitrous oxide in general anaesthesia: meta-analysis of intraoperative awareness and postoperative emesis in randomized controlled trials. Br J Anaesth 1996; 76:186-193.
13. Tramer M, Moore A, McQuay H. Meta-analytic comparison of prophylactic antiemetic efficacy for postoperative nausea and vomiting: propofol anaesthesia vs omitting nitrous oxide vs total i.v. anaesthesia with propofol. Br J Anaesth 1997; 78:256-259.
14. Splinter WM, Roberts DJ, Rhine EJ, et al. Nitrous oxide does not increase vomiting in children after myringotomy. Can J Anaesth 1995; 42:274-276.
15. Splinter WM, Komocar L. Nitrous oxide does not increase vomiting after dental restorations in children. Anesth Analg 1997; 84:506-508.
16. Apfel CC, Kranke P, Katz MH, et al. Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design. Br J Anaesth 2002; 88:659-668. More work on the factors that affect POV.
17. Johannesson GP, Floren M, Lindahl SG. Sevoflurane for ENT-surgery in children: a comparison with halothane. Acta Anaesth Scand 1995; 39:546-550.
18. Meretoja OA, Taivainen T, Raiha L, et al. Sevoflurane-nitrous oxide or halothane-nitrous oxide for paediatric bronchoscopy and gastroscopy. Br J Anaesth 1996; 76:767-771.
19. Moore JK, Moore EW, Elliott RA, et al. Propofol and halothane versus sevoflurane in paediatric day-case surgery: induction and recovery characteristics. Br J Anaesth 2003; 90:461-466.
20. Chhibber AK, Lustik SJ, Thakur R, et al. Effects of anticholinergics on postoperative vomiting, recovery, and hospital stay in children undergoing tonsillectomy with or without adenoidectomy. Anesthesiology 1999; 90:697-700.
21. Schreiner MS, Nicolson SC, Martin T, Whitney L. Should children drink before discharge from day surgery? Anesthesiology 1992; 76:528-533.
22. Scuderi PE, James RL, Harris L, Mims GR III. Antiemetic prophylaxis does not improve outcomes after outpatient surgery when compared to symptomatic treatment. Anesthesiology 1999; 90:360-371.
23. Watcha MF. The cost-effective management of postoperative nausea and vomiting. Anesthesiology 2000; 92:931-933.
24. White PF, Watcha MF. Postoperative nausea and vomiting: prophylaxis versus treatment. Anesth Analg 1999; 89:1337-1339.
25. Fisher DM. Surrogate end points. Are they meaningful? Anesthesiology 1994; 81:795-796.
26. Carroll NV, Miederhoff P, Cox FM, Hirsch JD. Postoperative nausea and vomiting after discharge from outpatient surgery centers. Anesth Analg 1995; 80:903-909.
27. Hill RP, Lubarsky DA, Phillips-Bute B, et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology 2000; 92:958-967.
28. Kranke P, Morin AM, Roewer N, et al. The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2002; 95:133-143.
29. Kranke P, Morin AM, Roewer N, Eberhart LH. Dimenhydrinate for prophylaxis of postoperative nausea and vomiting: a meta-analysis of randomized controlled trials. Acta Anaesth Scand 2003; 46:238-244.
30. Domino KB, Anderson EA, Polissar NL, Posner KL. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis. Anesth Analg 1999; 88:1370-1379.
31. Henzi I, Sonderegger J, Tramer MR. Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Can J Anaesth 2000; 47:537-551.
32. Gan TJ, White PF, Scuderi PE, et al. FDA 'black box' warning regarding use of droperidol for postoperative nausea and vomiting: is it justified? Anesthesiology 2002; 97:287.
33. Kao LW, Kirk MA, Evers SJ, Rosenfeld SH. Droperidol, QT prolongation, and sudden death: what is the evidence? Ann Emerg Med 2003; 41:546-558.
34. Scuderi PE. Droperidol: many questions, few answers. Anesthesiology 2003; 98:289-290. Editorial, questioning the data on which the FDA decision to avoid droperidol was based.
35. Tramer MR, Reynolds DJ, Goodman NW. Whose drug is it anyway? Lancet 2001; 358:1275.
36. White PF. Droperidol: a cost-effective antiemetic for over thirty years. Anesth Analg 2002; 95:789-790. Another editorial questioning the data on which the decision to avoid droperidol was based.
37. Sennaraj B, Shende D, Sadhasivam S, et al. Management of post-strabismus nausea and vomiting in children using ondansetron: a value-based comparison of outcomes. Br J Anaesth 2002; 89:473-478.
38. Sadhasivam S, Shende D, Madan R. Prophylactic ondansetron in prevention of postoperative nausea and vomiting following pediatric strabismus surgery: a dose-response study. Anesthesiology 2000; 92:1035-1042.
39. Cieslak GD, Watcha MF, Phillips MB, Pennant JH. The dose-response relation and cost-effectiveness of granisetron for the prophylaxis of pediatric postoperative emesis. Anesthesiology 1996; 85:1076-1085.
40. Diemunsch P, Korttila K, Leeser J, et al. Oral dolasetron mesylate for prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. The Oral Dolasetron PONV Prevention Study Group. J Clin Anesth 1998; 10:145-152.
41. Diemunsch P, Leeser J, Feiss P, et al. Intravenous dolasetron mesilate ameliorates postoperative nausea and vomiting. Can J Anaesth 1997; 44:173-181.
42. Korttila K, Ciergue F, Leeser J, et al. Intravenous dolasetron and ondansetron in prevention of postoperative nausea and vomiting: a multicenter, double-blind, placebo-controlled study. Acta Anaesth Scand 1997; 41:914-922.
43. Paech MJ, Rucklidge MW, Banks SL, et al. The efficacy and cost-effectiveness of prophylactic 5-hydroxytryptamine3 receptor antagonists: tropisetron, ondansetron and dolasetron. Anaesth Intensive Care 2003; 31:11-17.
44. Olutoye O, Jantzen EC, Alexis R, et al. A comparison of the costs and efficacy of ondansetron and dolasetron in the prophylaxis of postoperative vomiting in pediatric patients undergoing ambulatory surgery. Anesth Analg 2003; 97:390-396. Study determining the dose of dolasteron with equivalent efficacy to ondansetron 0.1 mg/kg for POV prophylaxis.
45. Ang C, Habre W, Sims C. Tropisetron reduces vomiting after tonsillectomy in children. Br J Anaesth 1998; 80:761-763.
46. Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000; 90:186-194.
47. Elhakim M, Nafie M, Mahmoud K, Atef A. Dexamethasone 8 mg in combination with ondansetron 4 mg appears to be the optimal dose for the prevention of nausea and vomiting after laparoscopic cholecystectomy. Can J Anaesth 2002; 49:922-926.
48. Subramaniam B, Madan R, Sadhasivam S, et al. Dexamethasone is a cost-effective alternative to ondansetron in preventing PONV after paediatric strabismus repair. Br J Anaesth 2001; 86:84-89.
49. Fujii Y, Tanaka H. Granisetron versus granisetron/dexamethasone combination for the treatment of nausea, retching, and vomiting after major gynecologic surgery: a randomized, double-blind study. Clin Ther 2003; 25:507-514.
50. Biswas BN, Rudra A. Comparison of granisetron and granisetron plus dexamethasone for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy. Acta Anaesth Scand 2003; 47:79-83.
51. Wang C, Xu N, Xiong LZ, et al. Dexamethasone enhances the effect of tropisetron and ondansetron against nausea and vomiting after patient-controlled analgesia. Di Yi Junyi Daxue Xuebao 2002; 22:159-161.
52. Coloma M, White PF, Markowitz SD, et al. Dexamethasone in combination with dolasetron for prophylaxis in the ambulatory setting: effect on outcome after laparoscopic cholecystectomy. Anesthesiology 2002; 96:1346-1350.
53. Liu YH, Li MJ, Wang PC, et al. Use of dexamethasone on the prophylaxis of nausea and vomiting after tympanomastoid surgery. Laryngoscope 2001; 111:1271-1274.
54. Scuderi PE, James RL, Harris L, et al. Multimodal antiemetic management prevents early postoperative vomiting after outpatient laparoscopy. Anesth Analg 2000; 91:1408-1414.
55. Negri PD, Ivani G. Management of postoperative nausea and vomiting in children. Paediatr Drugs 2002; 4:717-728. More recent review of the problem of PONV in children.
56. Lee A, Done ML. The use of nonpharmacologic techniques to prevent postoperative nausea and vomiting: a meta-analysis. Anesth Analg 1999; 88:1362-1369.
57. Khalil S, Rodarte A, Weldon BC, et al. Intravenous ondansetron in established postoperative emesis in children. S3A-381 Study Group. Anesthesiology 1996; 85:270-276.
58. Kovac AL, O'Connor TA, Pearman MH, et al. Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial. J Clin Anesth 1999; 11:453-459.